SeqOne expands its commercial presence in Middle Eastern markets
Genomics analysis becomes more accessible in MENA region: a new era for genetic diagnostics
Montpellier, France -- SeqOne Genomics, a leader in the field of next generation genomics analysis, announces today a distribution partnership with Global Diagnostic Solutions Ltd (GDS) to commercialize SeqOne’s revolutionary genomics analysis software platform in Middle Eastern markets.
Under the terms of this agreement, Global Diagnostic Solutions Ltd. will be responsible for the Business Development, Technical & Logistics Support of SeqOne’s genomic analysis platform in the Middle-East North Africa (MENA) Region: Egypt, Turkey, Bahrain, the Kingdom of Saudi Arabia, Algeria, Tunisia, Morocco and Oman & UAE.
About SeqOne Genomics
A company focused on developing state-of-the-art genomic analysis tools for clinical applications in the field of rare and hereditary diseases and oncology.
About Global Diagnostic Solution Ltd.
About Global diagnostic solutions Ltd.: a company with the objective of representing tomorrow’s Molecular Genetics. Mapping all healthcare services present in the field of personalized medicine and bioinformatics diagnostics tools we choose the best diagnostic European leaders, we bring them through the MENA Region, we communicate their technology leading the genomic transformation.
-
Most popular related searches
Customer comments
No comments were found for SeqOne expands its commercial presence in Middle Eastern markets. Be the first to comment!